npj Breast Cancer : Impact Factor & More
eISSN: 2374-4677pISSN: 2374-4677
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.73
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on npj Breast Cancer
npj Breast Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2890 | USD 3390 | GBP 2590 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Breast Cancer Research Foundation |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in npj Breast Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in npj Breast Cancer
Combining orally available selective estrogen receptor degraders with pan-HER tyrosine kinase inhibitor neratinib in pre-clinical models of HER2+/ER+ breast cancer
- 5 Aug 2026
- npj Breast Cancer
Preventive effect of compression on breast cancer–related lymphedema after docetaxel chemotherapy: a randomized controlled trial
- 5 Aug 2026
- npj Breast Cancer
Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control
- 29 Jul 2026
- NPJ Breast Cancer
The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
- 21 Jul 2026
- NPJ breast cancer
Novel (Z)-endoxifen-related new chemical entities exhibit potent anti-cancer activity in ERα+ breast cancer.
- 20 Jul 2026
- NPJ breast cancer
Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data.
- 11 Jul 2026
- NPJ breast cancer
Combining orally available selective estrogen receptor degraders with pan-HER tyrosine kinase inhibitor neratinib in pre-clinical models of HER2+/ER+ breast cancer
- 5 Aug 2026
- npj Breast Cancer
Preventive effect of compression on breast cancer–related lymphedema after docetaxel chemotherapy: a randomized controlled trial
- 5 Aug 2026
- npj Breast Cancer
Circulating tumor DNA as an arbitrator for postmastectomy radiotherapy: bridging molecular residual disease and locoregional control
- 29 Jul 2026
- NPJ Breast Cancer
The WinPro trial: window-of-opportunity study of endocrine therapy with micronised progesterone in ER-positive breast cancer.
- 21 Jul 2026
- NPJ breast cancer
Novel (Z)-endoxifen-related new chemical entities exhibit potent anti-cancer activity in ERα+ breast cancer.
- 20 Jul 2026
- NPJ breast cancer
Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data.
- 11 Jul 2026
- NPJ breast cancer
FAQs on npj Breast Cancer
How long has npj Breast Cancer been actively publishing? 
What is the publishing frequency of npj Breast Cancer?
How many articles did npj Breast Cancer publish last year?
What is the eISSN & pISSN for npj Breast Cancer?
What is Citescore for npj Breast Cancer?
What is SNIP score for npj Breast Cancer?
What is the SJR for npj Breast Cancer?
Who is the publisher of npj Breast Cancer?
